中山市佐莱太阳能科技有限公司
20人以下
公司优势
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
Introduction of Immunowake Biopharmaceutical Co., Ltd
Immunowake is a global biotech company dedicated to developing and commercializing novel bispecific antibodies for tumor treatment. The company focuses on antibody activation of the immune system, improving the tumor microenvironment, and treating solid tumors. Immunowake aims to develop blockbuster drugs that can compete with those from major Western pharmaceutical companies to address unmet clinical needs. The company has completed its Series A financing. The U.S. R&D center is located in Birmingham, while the R&D center in China is based in Shanghai Zhangjiang Pharmaceutical Valley. In the future, Shanghai will serve as the global R&D hub for Immunowake.
Dr. Xiaoyun Wu, the founder of Immunowake, is a seasoned expert and serial entrepreneur in the field of tumor immunotherapy. With over three decades of work and study experience in the United States, Dr. Wu is an accomplished entrepreneur with strong academic credentials and entrepreneurial expertise. At the end of 2021, Dr. Wu led the core team, research achievements, and technology platforms back to China, initiating a new chapter for Chinese cancer drugs in the global market. Currently, two immunotherapeutic bispecific antibodies are actively preparing for IND application materials, with plans for dual Sino-US submissions next year. Through the collective efforts of the Immunowake team, we aim to contribute to the internationalization of Chinese new drugs.
河北顺安远大环保科技股份有限公司由保定宏海投资有限公司与长沙远大住宅工业集团股份有限公司共同创立，总投资额达18.3亿元。河北顺安远大装配式建筑产业园占地面积超过600亩，总规划建筑面积约为28.8万平方米。其中包括大约16万平方米的PC车间，以及约12.8万平方米的办公楼、专家公寓、综合实验楼、国家级考察基地、会议中心、培训基地和公寓楼体育馆等配套设施。此项目已被河北省重点建设领导小组办公室列为2018年度河北省重点项目，并被誉为全国规模领先的国际化花园式工厂。
中港英文学校于1993年在香港筹划，并于1994年9月正式落户广东省中山市开办一所双语学校，成为华南地区最早的双语国际学校之一。1997年，再扩办江门校区。经过23年的努力，目前中山和江门两地的学生总数已超过4000人，其中超过50%为港澳台及来自五大洲的外籍学生。学校已经形成了从幼儿园到高中的完整教育体系，并先后被国家民政部和教育部授予“全国先进民间组织”和“全国先进学校”的荣誉称号。